---
layout: page-fullwidth
title: "Speakers & Presentations"
header: no
permalink: /speakers/
---

<div id="speaker1" style="display: flex; flex-direction: column;">

<h4>Mark Van der Laan, University of California at Berkeley</h4>

<p>
<img class="imgfloat" src="../docs/mark_profile.jpeg"/>

Mark, who pioneered the widely acclaimed targeted maximum likelihood estimator (TMLE) approach for causal inference, will elucidate the validity of the framework in the context of augmenting control arms to generate valid and reliable evidence. 

</p>


<!-- <h4>Abstract</h4>


</div> -->


<div id="speaker2" style="display: flex; flex-direction: column;">

<h4>Pallavi Mishra-Kalyani, US Food and Drug Administration (FDA)</h4>

<p>
<img class="imgfloat" src="../docs/Pallavi.jpeg"/>

Pallavi will highlight current regulatory thinking in the area and provide salient aspects of relevant guidelines aimed at fostering innovation in drug development. 
</p>


<div id="speaker3" style="display: flex; flex-direction: column;">

<h4>Mingyang Shan, Eli Lilly</h4>

<p>
<img class="imgfloat" src="../docs/mingyang.jpeg"/>

From the perspective of pharmaceutical industry, Mingyang will share pertinent experiences with reference to alternative sensitivity analysis strategies in dealing with the issue of unmeasured confounding when incorporating external controls in RCTs. 
</p>



<div id="speaker4" style="display: flex; flex-direction: column;">

<h4>Miguel Hernan, Harvard University</h4>

<p>
<img class="imgfloat" src="../docs/Miguel.jpeg"/>

Miguel, who has played a pivotal role in the introduction of the target trial emulation framework, will discuss novel methods for causal inference in the context of CIDs, including external controls. 

</p>


<div id="speaker5" style="display: flex; flex-direction: column;">

<h4>Demissie Alemayehu, Pfizer</h4>

<p>
<img class="imgfloat" src="../docs/Demissie.jpg"/>

Demissie will provide a synthesis of the ideas presented by the speakers and engage the participants and the audience to generate further insights.
</p>
